Literature DB >> 18432547

Neuromuscular junction dysfunction in Miller Fisher syndrome.

M P Silverstein1, S Zimnowodzki, J C Rucker.   

Abstract

The Miller Fisher syndrome (MFS) is a variant of Guillain-Barre syndrome with the clinical triad of areflexia, ataxia, and ophthalmoparesis. The classic pathologic mechanism of disease is considered to be peripheral nerve demyelination. We present a patient with binocular diplopia and a diagnosis of myasthenia gravis from 15 years prior. Electrophysiologic studies revealed a decremental response on repetitive nerve stimulation, suggesting recurrent myasthenia. However, pupillary light-near dissociation and areflexia were present and positive anti-GQ1b antibodies confirmed MFS. This patient highlights a developing recognition of impaired neuromuscular transmission in MFS. His presentation is discussed in the context of the animal and human literature on neuromuscular junction abnormalities in MFS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18432547     DOI: 10.1080/08820530802049996

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  6 in total

Review 1.  Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.

Authors:  Jaap J Plomp; Hugh J Willison
Journal:  J Physiol       Date:  2009-06-29       Impact factor: 5.182

2.  Miller Fisher syndrome mimicking ocular myasthenia gravis.

Authors:  Scott A Anthony; Matthew J Thurtell; R John Leigh
Journal:  Optom Vis Sci       Date:  2012-12       Impact factor: 1.973

3.  Clinical characteristics and outcomes of patients with overlapping Miller Fisher syndrome and myasthenia gravis.

Authors:  Jun-Liang Yuan; Yan Xing; Wen-Li Hu
Journal:  Arch Med Sci       Date:  2019-12-31       Impact factor: 3.318

Review 4.  Guillain-Barré syndrome associated with myasthenia gravis: Three cases report and a literature review.

Authors:  Yayun Cao; Mengcui Gui; Suqiong Ji; Bitao Bu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

5.  Case Report: A Patient Diagnosed With Miller Fisher Syndrome and Myasthenia Gravis at the Same Time.

Authors:  Nan Chen; Hanyu Cai; Jianhua Cheng
Journal:  Front Neurol       Date:  2022-02-07       Impact factor: 4.003

Review 6.  The clinical features of patients concurrent with Guillain-Barre syndrome and myasthenia gravis.

Authors:  Junliang Yuan; Juan Zhang; Bingwei Zhang; Wenli Hu
Journal:  Neurosciences (Riyadh)       Date:  2018-01       Impact factor: 0.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.